TGen-TD2-Scottsdale Healthcare breast cancer pilot study shows value of proteomic mapping
The Side-Out Foundation's breast cancer pilot study, led by the Translational Genomics Research Institute (TGen), Translational Drug Development (TD2) and Scottsdale Healthcare, has shown that cancer patients do better when ...
Jul 17, 2013
0
0